Frontier Biotechnologies Inc. (SHA:688221)
China
· Delayed Price · Currency is CNY 20.42
+1.20 (6.24%)
At close: Mar 10, 2026
Frontier Biotechnologies Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2017 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2017 |
| Cash & Equivalents | - | 248.98 | 526.66 | 550.89 | 800.85 | Upgrade
|
| Trading Asset Securities | - | 600.53 | 415.06 | 690.11 | 679.36 | Upgrade
|
| Cash & Short-Term Investments | 692.14 | 849.51 | 941.72 | 1,241 | 1,480 | Upgrade
|
| Cash Growth | -18.52% | -9.79% | -24.12% | -16.16% | -16.78% | Upgrade
|
| Accounts Receivable | - | 34.75 | 63.01 | 36.14 | 22.34 | Upgrade
|
| Other Receivables | - | 227.7 | 2.37 | 10.55 | 1.13 | Upgrade
|
| Receivables | - | 262.45 | 65.38 | 46.68 | 23.48 | Upgrade
|
| Inventory | - | 41.06 | 59 | 55.61 | 38.62 | Upgrade
|
| Other Current Assets | - | 69.6 | 36.68 | 62.78 | 35.2 | Upgrade
|
| Total Current Assets | - | 1,223 | 1,103 | 1,406 | 1,578 | Upgrade
|
| Property, Plant & Equipment | - | 393.31 | 793.02 | 728.06 | 605.76 | Upgrade
|
| Long-Term Investments | - | 29.96 | - | - | - | Upgrade
|
| Other Intangible Assets | - | 149.32 | 229.18 | 257.22 | 258.44 | Upgrade
|
| Long-Term Deferred Charges | - | 2.03 | 0.94 | 2.74 | 3.12 | Upgrade
|
| Other Long-Term Assets | - | 14.89 | 14.21 | 16.76 | 87.8 | Upgrade
|
| Total Assets | - | 1,812 | 2,140 | 2,411 | 2,533 | Upgrade
|
| Accounts Payable | - | 0.88 | 1.13 | 2.69 | 3.32 | Upgrade
|
| Accrued Expenses | - | 25.11 | 37.39 | 41.84 | 38.98 | Upgrade
|
| Short-Term Debt | - | 283.97 | 202.3 | 110.64 | 52.19 | Upgrade
|
| Current Portion of Long-Term Debt | - | 43.01 | 104.06 | 46 | 227.77 | Upgrade
|
| Current Portion of Leases | - | 0.23 | 2.4 | 4.42 | 5.09 | Upgrade
|
| Current Unearned Revenue | - | 2.68 | 5.83 | 0.06 | - | Upgrade
|
| Other Current Liabilities | - | 39.34 | 27.04 | 71.58 | 72.14 | Upgrade
|
| Total Current Liabilities | - | 395.2 | 380.16 | 277.23 | 399.49 | Upgrade
|
| Long-Term Debt | - | 79.36 | 71.42 | 117.12 | 7.5 | Upgrade
|
| Long-Term Leases | - | - | 0.17 | 0.45 | 0.41 | Upgrade
|
| Long-Term Unearned Revenue | - | 196.26 | 329.35 | 323.54 | 269.41 | Upgrade
|
| Other Long-Term Liabilities | - | - | 16.35 | 21.08 | 25.59 | Upgrade
|
| Total Liabilities | - | 670.83 | 797.44 | 739.41 | 702.41 | Upgrade
|
| Common Stock | - | 374.58 | 374.58 | 374.58 | 359.76 | Upgrade
|
| Additional Paid-In Capital | - | 2,723 | 2,723 | 2,723 | 2,540 | Upgrade
|
| Retained Earnings | - | -1,956 | -1,755 | -1,426 | -1,069 | Upgrade
|
| Comprehensive Income & Other | - | 0.02 | 0.01 | 0.03 | -0.05 | Upgrade
|
| Total Common Equity | 981.52 | 1,141 | 1,343 | 1,671 | 1,830 | Upgrade
|
| Shareholders' Equity | 981.52 | 1,141 | 1,343 | 1,671 | 1,830 | Upgrade
|
| Total Liabilities & Equity | - | 1,812 | 2,140 | 2,411 | 2,533 | Upgrade
|
| Total Debt | 374.34 | 406.56 | 380.35 | 278.62 | 292.96 | Upgrade
|
| Net Cash (Debt) | 317.8 | 442.95 | 561.37 | 962.38 | 1,187 | Upgrade
|
| Net Cash Growth | -28.25% | -21.09% | -41.67% | -18.94% | -32.01% | Upgrade
|
| Net Cash Per Share | 0.85 | 1.19 | 1.50 | 2.64 | 3.29 | Upgrade
|
| Filing Date Shares Outstanding | 380.58 | 374.58 | 374.58 | 374.58 | 359.76 | Upgrade
|
| Total Common Shares Outstanding | 374.58 | 374.58 | 374.58 | 374.58 | 359.76 | Upgrade
|
| Working Capital | - | 827.41 | 722.63 | 1,129 | 1,178 | Upgrade
|
| Book Value Per Share | 2.62 | 3.05 | 3.58 | 4.46 | 5.09 | Upgrade
|
| Tangible Book Value | 848.58 | 991.99 | 1,114 | 1,414 | 1,572 | Upgrade
|
| Tangible Book Value Per Share | 2.27 | 2.65 | 2.97 | 3.78 | 4.37 | Upgrade
|
| Buildings | - | 159.06 | 76.22 | 76.22 | - | Upgrade
|
| Machinery | - | 127.73 | 47.35 | 45.92 | 30.44 | Upgrade
|
| Construction In Progress | - | 147.74 | 695.97 | 622.9 | 582.29 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.